Al-Dwairi Rami, Saleh Omar, Aleshawi Abdelwahab, Alladkanie Zeinab, Al Deyabat Osama, Alasheh Acil, Adi Sharaf, Al-Howthi Mohammed
Division of Ophthalmology, Department of Special Surgery, Faculty of Medicine, Jordan University of Science and Technology, P.O. Box 3030, Irbid, 22110, Jordan.
Ophthalmol Ther. 2022 Apr;11(2):771-784. doi: 10.1007/s40123-022-00474-2. Epub 2022 Feb 11.
In cases of inadequate capsular support for intraocular lens (IOL) implantation, iris-claw IOL is a practical option. Iris-claw IOL can be implanted anteriorly or retropupillary. In this study, we compare the outcome of implantation of iris-claw IOL between anterior and retropupillary locations.
We retrospectively examined the characteristics and outcomes of patients who underwent iris-claw "Artisan" intraocular lens implantation (IOL) during the period of January 2014 to July 2020. The study population included all patients who underwent iris-claw IOL implantation, whether as a primary or secondary implantation, regardless of the causative indication. The study population was categorized by location of implantation and indication. The outcome was compared by visual acuity and postoperative complications.
In this study, 171 eyes of 151 patients were included. Iris-claw IOL was implanted anteriorly in 110 (64.3%) eyes. The most common indication for iris-claw IOL was complicated cataract surgery, followed by ectopia lentis and by trauma. Patients with retropupillary position achieved better visual outcome whatever the causative indication. Anterior iris-claw IOL patients had more high intraocular pressure readings and macular edema.
This study revealed that retropupillary iris-claw IOL may achieve better visual outcome without significant postoperative complications. Further prospective studies and trials on larger sample sizes are needed.
在人工晶状体(IOL)植入时囊袋支撑不足的情况下,虹膜爪式人工晶状体是一种实用的选择。虹膜爪式人工晶状体可植入到前方或瞳孔后。在本研究中,我们比较了虹膜爪式人工晶状体在前方和瞳孔后植入的效果。
我们回顾性研究了2014年1月至2020年7月期间接受虹膜爪式“Artisan”人工晶状体植入术的患者的特征和结果。研究人群包括所有接受虹膜爪式人工晶状体植入的患者,无论其为初次植入还是二次植入,也不论病因。研究人群按植入位置和病因进行分类。通过视力和术后并发症比较结果。
本研究纳入了151例患者的171只眼。110只眼(64.3%)将虹膜爪式人工晶状体植入到前方。虹膜爪式人工晶状体最常见的适应证是复杂白内障手术,其次是晶状体异位和外伤。无论病因如何,瞳孔后植入的患者视力结果更好。前方虹膜爪式人工晶状体植入的患者眼压读数较高和黄斑水肿的情况更多。
本研究表明,瞳孔后虹膜爪式人工晶状体可能获得更好的视力结果且无明显术后并发症。需要进一步开展更大样本量的前瞻性研究和试验。